stars 1 stars 2 stars 3

iVAC 2L is PulseCath’s percutaneous pulsatile mechanical circulatory support device, designed to provide temporary left ventricular support in patients with impaired left ventricular function. The iVAC 2L provides up to 2.0 L/min of circulatory support and is intended for left ventricular mechanical circulatory support for up to 24 hours. The iVAC 2L works in combination with a conventional intra-aortic balloon pump (IABP) driver and provides pulsatile support synchronized with the patient’s cardiac cycle. Patient groups that may benefit from iVAC 2L include patients undergoing high-risk percutaneous coronary intervention (HR-PCI), as well as patients with acute myocardial infarction, cardiogenic shock, and those undergoing high-risk ablation and mapping procedures. Learn more about iVAC 2L and PulseCath at www.pulsecath.com.

PulseCath BV Questions

The PulseCath BV annual revenue was $2 million in 2026.

Oren Malchin is the CEO of PulseCath BV.

9 people are employed at PulseCath BV.

PulseCath BV is based in Arnhem, Gelderland.

The NAICS codes for PulseCath BV are [33, 339].

The SIC codes for PulseCath BV are [384, 38].

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users